Deckers Brands has raised its full-year revenue growth outlook by 15% after delivering record quarterly revenue in Q3 of 2025 ...

Direct-to-consumer advertising can be a controversial topic in the pharma industry. While the US isn’t the only other country ...

Teva Pharmaceutical Industries Ltd (TEVA) reports a 9% revenue increase, driven by innovative and generics business, despite ...

2025年1月30日，制药公司梯瓦制药（TEVA）成交额为6.14亿美元，在当日美股中排第143名，成交额较昨日减少22.41%，当日成交量为3437.13万。 梯瓦制药（TEVA）于2025年1月30日跌3.78%，报17.84美元，该股过去5个交易日跌18.13%，整个1月跌19.06%，年初至今跌19.06%，过去52周涨47.44%。 *如果公司上市时间少于52周，则52周涨跌幅为上市至今 ...

HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...

Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic <a target=_blank href= ...

北京时间2025年01月31日02时31分，梯瓦制药（TEVA.us）股票出现异动，股价大幅下挫5.04%。截至发稿，该股报17.61美元/股，成交量2073.05万股， 换手率 1.83%，振幅5.23%。

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

Alzheimer’s Therapeutics MarketThe global Alzheimer’s therapeutics market is projected to experience significant growth, with an expected valuation of USD 3,052.3 million in 2023. The market is ...

Complex legal battle concerns ‘skinny label’ strategy used by generic drug makers, prompting a $235 million award | Pharma giant looks for enhanced damages due to ‘wilful infringement’, while opponent ...

The FDA accepted applications for a golimumab biosimilar, while Samsung Biologics reported record sales, and a Japanese ...